Literature DB >> 20018631

Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus.

Trine N Jørgensen1, Jennifer Alfaro, Hilda L Enriquez, Chao Jiang, William M Loo, Stephanie Atencio, Melanie R Gubbels Bupp, Christina M Mailloux, Troy Metzger, Shannon Flannery, Stephen J Rozzo, Brian L Kotzin, Mario Rosemblatt, María Rosa Bono, Loren D Erickson.   

Abstract

Autoantibodies are of central importance in the pathogenesis of Ab-mediated autoimmune disorders. The murine lupus susceptibility locus Nba2 on chromosome 1 and the syntenic human locus are associated with a loss of immune tolerance that leads to antinuclear Ab production. To identify gene intervals within Nba2 that control the development of autoantibody-producing B cells and to determine the cellular components through which Nba2 genes accomplish this, we generated congenic mice expressing various Nba2 intervals where genes for the FcgammaR, SLAM, and IFN-inducible families are encoded. Analysis of congenic strains demonstrated that the FcgammaR and SLAM intervals independently controlled the severity of autoantibody production and renal disease, yet are both required for lupus susceptibility. Deregulated homeostasis of terminally differentiated B cells was found to be controlled by the FcgammaR interval where FcgammaRIIb-mediated apoptosis of germinal center B cells and plasma cells was impaired. Increased numbers of activated plasmacytoid dendritic cells that were distinctly CD19+ and promoted plasma cell differentiation via the proinflammatory cytokines IL-10 and IFNalpha were linked to the SLAM interval. These findings suggest that SLAM and FcgammaR intervals act cooperatively to influence the clinical course of disease through supporting the differentiation and survival of autoantibody-producing cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018631      PMCID: PMC2841050          DOI: 10.4049/jimmunol.0901322

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  68 in total

1.  The B cell inhibitory Fc receptor triggers apoptosis by a novel c-Abl family kinase-dependent pathway.

Authors:  Shiang-Jong Tzeng; Silvia Bolland; Kazunori Inabe; Tomohiro Kurosaki; Susan K Pierce
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

2.  Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors.

Authors:  Jiquan Zhang; Anna Raper; Noriko Sugita; Ravi Hingorani; Mariolina Salio; Michael J Palmowski; Vincenzo Cerundolo; Paul R Crocker
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

3.  Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.

Authors:  Amanda L Blasius; Marina Cella; Jorge Maldonado; Toshiyuki Takai; Marco Colonna
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

4.  Regulation of B cell tolerance by the lupus susceptibility gene Ly108.

Authors:  Kirthi Raman Kumar; Liunan Li; Mei Yan; Madhavi Bhaskarabhatla; Angela B Mobley; Charles Nguyen; Jill M Mooney; John D Schatzle; Edward K Wakeland; Chandra Mohan
Journal:  Science       Date:  2006-06-16       Impact factor: 47.728

5.  Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis.

Authors:  Hong Xin; Sanjay D'Souza; Trine N Jørgensen; Andrew T Vaughan; Peter Lengyel; Brian L Kotzin; Divaker Choubey
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

6.  Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity.

Authors:  Camie W Chan; Emily Crafton; Hong-Ni Fan; James Flook; Kiyoshi Yoshimura; Mario Skarica; Dirk Brockstedt; Thomas W Dubensky; Monique F Stins; Lewis L Lanier; Drew M Pardoll; Franck Housseau
Journal:  Nat Med       Date:  2006-01-29       Impact factor: 53.440

7.  SLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cells.

Authors:  Bence Réthi; Péter Gogolák; Istvan Szatmari; Agota Veres; Erika Erdôs; Laszlo Nagy; Eva Rajnavölgyi; Cox Terhorst; Arpád Lányi
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

8.  Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice.

Authors:  Melanie R Gubbels; Trine N Jørgensen; Troy E Metzger; Katherine Menze; Heather Steele; Shannon A Flannery; Stephen J Rozzo; Brian L Kotzin
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

9.  Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.

Authors:  Andrew L Mellor; Babak Baban; Phillip R Chandler; Anna Manlapat; David J Kahler; David H Munn
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

10.  Failed up-regulation of the inhibitory IgG Fc receptor Fc gamma RIIB on germinal center B cells in autoimmune-prone mice is not associated with deletion polymorphisms in the promoter region of the Fc gamma RIIB gene.

Authors:  Ziaur S M Rahman; Tim Manser
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

View more
  34 in total

1.  Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.

Authors:  Edward van Opstal; Glynis L Kolling; John H Moore; Christine M Coquery; Nekeithia S Wade; William M Loo; David T Bolick; Jae Hyun Shin; Loren D Erickson; Cirle A Warren
Journal:  J Infect Dis       Date:  2016-02-24       Impact factor: 5.226

2.  B-Cell Depletion Promotes Aortic Infiltration of Immunosuppressive Cells and Is Protective of Experimental Aortic Aneurysm.

Authors:  Basil Schaheen; Emily A Downs; Vlad Serbulea; Camila C P Almenara; Michael Spinosa; Gang Su; Yunge Zhao; Prasad Srikakulapu; Cherié Butts; Coleen A McNamara; Norbert Leitinger; Gilbert R Upchurch; Akshaya K Meher; Gorav Ailawadi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-15       Impact factor: 8.311

Review 3.  Regulatory roles of the tumor necrosis factor receptor BCMA.

Authors:  Christine M Coquery; Loren D Erickson
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

4.  Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE.

Authors:  Ravichandran Panchanathan; Xin Duan; Muthuvel Arumugam; Hui Shen; Hongzhu Liu; Divaker Choubey
Journal:  Mol Immunol       Date:  2011-09-23       Impact factor: 4.407

Review 5.  Absent in Melanoma 2 proteins in SLE.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Clin Immunol       Date:  2017-01-03       Impact factor: 3.969

6.  The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.

Authors:  Anna E Koh; Sarah W Njoroge; Marianela Feliu; Alexis Cook; Martin K Selig; Yvette E Latchman; Arlene H Sharpe; Robert B Colvin; Elahna Paul
Journal:  J Autoimmun       Date:  2011-05-10       Impact factor: 7.094

7.  Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus.

Authors:  Ravichandran Panchanathan; Xin Duan; Hui Shen; Vijay A K Rathinam; Loren D Erickson; Katherine A Fitzgerald; Divaker Choubey
Journal:  J Immunol       Date:  2010-11-05       Impact factor: 5.422

Review 8.  Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.

Authors:  Divaker Choubey
Journal:  Immunol Lett       Date:  2012-07-24       Impact factor: 3.685

9.  The AIM2-like Receptors Are Dispensable for the Interferon Response to Intracellular DNA.

Authors:  Elizabeth E Gray; Damion Winship; Jessica M Snyder; Stephanie J Child; Adam P Geballe; Daniel B Stetson
Journal:  Immunity       Date:  2016-08-02       Impact factor: 31.745

10.  AIM2 facilitates the apoptotic DNA-induced systemic lupus erythematosus via arbitrating macrophage functional maturation.

Authors:  Weijuan Zhang; Yanxing Cai; Wei Xu; Zhinan Yin; Xiaoming Gao; Sidong Xiong
Journal:  J Clin Immunol       Date:  2013-03-12       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.